Drugs / BC Pram Ins
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03512236 | Apr 2018 → Feb 2019 | type 1 diabetes mellitus | Adocia | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BC Pram Ins | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03512236 ↗ |
| Known as | BioChaperone pramlintide human insulin | “simultaneous administrations of BioChaperone® pramlintide human insulin (BC Pram Ins) and placebo” NCT03512236 ↗ |
| Route | Subcutaneous | “Single subcutaneous injection of BC Pram Ins” NCT03512236 ↗ |